Form 4: MOBIX LABS Director Frederick Goerner Reports Significant RSU Grant and Increased Equity Stake

MOBIX LABS Director Frederick C. Goerner reported the acquisition of 131,356 Class A Common Stock through a Restricted Stock Unit grant, increasing his direct beneficial ownership to 1,436,525 shares, with 90% vesting immediately.

Summary

• Frederick C. Goerner, a Director of MOBIX LABS, INC. (MOBX), reported a transaction on July 9, 2025.
• Acquired 131,356 shares of Class A Common Stock through a Restricted Stock Unit (RSU) grant at a price of $0.00 per share.
• 90% of these RSUs vested immediately upon grant on July 9, 2025.
• The remaining 10% of the RSU award will vest on October 1, 2025.
• Following this transaction, Goerner directly beneficially owns 1,436,525 shares of Class A Common Stock.
• Goerner also holds derivative securities, including 20,000 options with an exercise price of $4.18 expiring on August 10, 2030, and 133,416 options with an exercise price of $6.84 expiring on April 4, 2032, both of which are fully vested and exercisable.

Sentiment

Score: 7

Explanation: The document reports a routine equity grant to a director, which is generally positive as it aligns management interests with shareholders. There are no negative financial disclosures or significant risks beyond standard equity dilution.

Positives

• Director Frederick C. Goerner received a significant grant of 131,356 Restricted Stock Units, indicating continued alignment of management interests with shareholders.
• 90% of the RSU award vested immediately upon grant, providing immediate equity ownership.
• The director's total direct beneficial ownership of Class A Common Stock increased to 1,436,525 shares, demonstrating a substantial stake in the company.
• Existing stock options are fully vested and exercisable, providing flexibility for the director.

Negatives

• The RSU grant was at a price of $0.00, which represents a non-cash compensation expense for the company and potential future dilution for existing shareholders.

Risks

• Future dilution from the vesting of the remaining 10% of the RSU award on October 1, 2025.
• Potential future dilution from the exercise of outstanding stock options (20,000 at $4.18 and 133,416 at $6.84).

Future Outlook

The remaining 10% of the Restricted Stock Unit award granted to Director Frederick C. Goerner is scheduled to vest on October 1, 2025, which will further increase his direct beneficial ownership of Class A Common Stock.

Industry Context

This Form 4 filing reflects a standard practice of executive compensation through equity grants in the technology and semiconductor industry, aiming to align the interests of directors and executives with long-term shareholder value. Such grants are common for companies like MOBIX LABS, which operate in a capital-intensive and innovation-driven sector.

Comparison to Industry Standards

• Equity grants, particularly Restricted Stock Units (RSUs) with vesting schedules, are a common component of executive and director compensation across the technology and semiconductor industries.
• The grant of 131,356 RSUs to a director, with a significant portion vesting immediately, is consistent with practices seen in companies of similar size and growth stage, such as those observed at emerging semiconductor firms or fabless design companies.
• For instance, companies like Ambarella (AMBA) or indie Semiconductor (INDI) often utilize similar equity incentive structures to attract and retain talent and align interests with long-term performance, though specific grant sizes vary based on individual roles and company-specific compensation philosophies.

Stakeholder Impact

• Shareholders: The grant of 131,356 Restricted Stock Units (RSUs) to a director, while aligning interests, represents potential future dilution of existing shares. However, the increased direct beneficial ownership of 1,436,525 shares by a director can be viewed positively as it signifies strong insider commitment.

Next Steps

• The remaining 10% of the RSU award will vest on October 1, 2025.

Key Dates

Keywords

MOBIX LABS, MOBX, Form 4, SEC filing, insider transaction, beneficial ownership, Restricted Stock Units, RSU, stock options, director compensation, equity grant, insider holdings